Medibank Private Limited
MDBPFOTCHealthcare● Active
$3.90
+$0.00(+0.00%)
Market Cap$10.7B
P/E Ratio—
52W High$3.9
52W Low$2.77
Medibank Private Limited (MDBPF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MDBPF · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 18, 2026EPS Actual
$0.07
Est. $0.07 · -1.6%
Revenue
$3.00B
Est. $3.01B · -0.1%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 18, 2026
After Market Close
▼ Miss EPS
MDBPF reports quarterly as a OTC-listed Medical - Healthcare Plans company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 20, 2026 | $0.09 | — | — | — | $3.30B | — |
| ▼ Q1 FY2026 | Feb 18, 2026 | $0.07 | $0.07 | -1.6% | $3.00B | $3.01B | -0.1% |
| ▼ Q3 FY2025 | Aug 27, 2025 | $0.08 | $0.04 | -49.6% | $2.73B | $2.86B | -4.7% |
| ▲ Q1 FY2025 | Feb 26, 2025 | $0.06 | $0.08 | +18.6% | $2.71B | $2.66B | +2.2% |
| ◌ Q4 FY2024 | Nov 13, 2024 | — | — | — | — | — | — |
| ▼ Q3 FY2024 | Aug 21, 2024 | $0.07 | -$0.08 | -220.8% | $2.63B | $2.78B | -5.1% |
| ▲ Q1 FY2024 | Feb 22, 2024 | $0.07 | $0.08 | +14.5% | $1.39B | $2.71B | -48.8% |
| ▲ Q2 FY2023 | Jun 30, 2023 | $0.06 | $0.07 | +8.0% | $2.51B | $2.55B | -1.2% |
Q3 FY2026
Aug 20, 2026
EPS Actual
—
EPS Est.
$0.09
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 18, 2026Miss
EPS Actual
$0.07
EPS Est.
$0.07
EPS Surpr.
-1.6%
Revenue
$3.00B
Q3 FY2025
Aug 27, 2025Miss
EPS Actual
$0.04
EPS Est.
$0.08
EPS Surpr.
-49.6%
Revenue
$2.73B
Q1 FY2025
Feb 26, 2025Beat
EPS Actual
$0.08
EPS Est.
$0.06
EPS Surpr.
+18.6%
Revenue
$2.71B
Q4 FY2024
Nov 13, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 21, 2024Miss
EPS Actual
-$0.08
EPS Est.
$0.07
EPS Surpr.
-220.8%
Revenue
$2.63B
Q1 FY2024
Feb 22, 2024Beat
EPS Actual
$0.08
EPS Est.
$0.07
EPS Surpr.
+14.5%
Revenue
$1.39B
Q2 FY2023
Jun 30, 2023Beat
EPS Actual
$0.07
EPS Est.
$0.06
EPS Surpr.
+8.0%
Revenue
$2.51B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.10 | $0.10 | $0.10 | 1 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.11 | $0.11 | $0.11 | 1 |
| Q2 FY2024 | $0.10 | $0.10 | $0.10 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $6.8B | $6.8B | $6.8B | 1 |
| Q3 FY2025 | $4.2B | $4.2B | $4.2B | 1 |
| Q2 FY2025 | $6.7B | $6.7B | $6.7B | 1 |
| Q2 FY2024 | $6.2B | $6.2B | $6.2B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2026 | Feb 18, 2026 | -1.6% | $2.78 | $2.78 | +0.00% |
| ▼ Q3 FY2025 | Aug 27, 2025 | -49.6% | $3.17 | $3.17 | +0.00% |
| ▲ Q1 FY2025 | Feb 26, 2025 | +18.6% | $1.99 | $1.99 | +0.00% |
| ▼ Q3 FY2024 | Aug 21, 2024 | -220.8% | $1.99 | $1.99 | +0.00% |
| ▲ Q1 FY2024 | Feb 22, 2024 | +14.5% | $2.53 | $2.53 | +0.00% |
| ▲ Q2 FY2023 | Jun 30, 2023 | +8.0% | $2.05 | $2.05 | +0.00% |
| ▲ Q4 FY2022 | Dec 30, 2022 | +2.8% | $1.93 | $1.93 | +0.00% |
| ▼ Q2 FY2022 | Jun 30, 2022 | -18.0% | $2.10 | $2.10 | +0.00% |
Q1 FY2026+0.00%
Report Date
Feb 18, 2026
EPS Beat/Miss
-1.6%
Price Before
$2.78
Price After
$2.78
Q3 FY2025+0.00%
Report Date
Aug 27, 2025
EPS Beat/Miss
-49.6%
Price Before
$3.17
Price After
$3.17
Q1 FY2025+0.00%
Report Date
Feb 26, 2025
EPS Beat/Miss
+18.6%
Price Before
$1.99
Price After
$1.99
Q3 FY2024+0.00%
Report Date
Aug 21, 2024
EPS Beat/Miss
-220.8%
Price Before
$1.99
Price After
$1.99
Q1 FY2024+0.00%
Report Date
Feb 22, 2024
EPS Beat/Miss
+14.5%
Price Before
$2.53
Price After
$2.53
Q2 FY2023+0.00%
Report Date
Jun 30, 2023
EPS Beat/Miss
+8.0%
Price Before
$2.05
Price After
$2.05
Q4 FY2022+0.00%
Report Date
Dec 30, 2022
EPS Beat/Miss
+2.8%
Price Before
$1.93
Price After
$1.93
Q2 FY2022+0.00%
Report Date
Jun 30, 2022
EPS Beat/Miss
-18.0%
Price Before
$2.10
Price After
$2.10
Avg Beat Reaction+0.00%
Avg Miss Reaction+0.00%
Beat Rate4 / 8 quarters
Largest Move+0.00% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MDBPF ends December
Medibank Private Limited (MDBPF) most recently reported earnings on February 18, 2026 for Q1 FY2026, posting EPS of $0.07 — missing the analyst consensus of $0.07 by -1.6%. The next MDBPF earnings date is expected around September 1, 2026.
Each quarter, investors track MDBPF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MDBPF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MDBPF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MDBPF earnings · 5 questionsMedibank Private Limited's next earnings report is expected around September 1, 2026. MDBPF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MDBPF historically reports after market close (AMC).
MDBPF earnings datewhen is MDBPF earningsMDBPF next earnings datewhen does MDBPF report earningsMDBPF earnings calendar
▸ Source: FMP · Medibank Private Limited SEC filings · US GAAP · Medibank Private Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026